Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
0(0%)
Results Posted
67%(4 trials)
Terminated
3(19%)

Phase Distribution

Ph not_applicable
1
6%
Ph phase_2
7
44%
Ph phase_3
3
19%
Ph phase_1
4
25%

Phase Distribution

4

Early Stage

7

Mid Stage

3

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
4(26.7%)
Phase 2Efficacy & side effects
7(46.7%)
Phase 3Large-scale testing
3(20.0%)
N/ANon-phased studies
1(6.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

6 of 12 finished

Non-Completion Rate

50.0%

6 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(6)
Terminated(6)
Other(1)

Detailed Status

Completed6
Not yet recruiting3
Withdrawn3
Terminated3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (26.7%)
Phase 27 (46.7%)
Phase 33 (20.0%)
N/A1 (6.7%)

Trials by Status

not_yet_recruiting319%
completed638%
withdrawn319%
unknown16%
terminated319%

Recent Activity

0 active trials
Showing 5 of 16
not_yet_recruiting

The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)

NCT07190534
completedphase_2

Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

NCT03037437
completedphase_1

A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

NCT01506973
not_yet_recruitingphase_2

Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome

NCT06862284
not_yet_recruitingphase_2

A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

NCT06816810
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT07190534

The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in Routine Clinical Care: a Patient Preference Trial (FFA Trial)

Not Yet Recruiting
NCT03037437Phase 2

Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer

Completed
NCT01506973Phase 1

A Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane in Pancreatic Cancer

Completed
NCT06862284Phase 2

Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome

Not Yet Recruiting
NCT06816810Phase 2

A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

Not Yet Recruiting
NCT04354870Phase 2

COVID-19 PrEP HCW HCQ Study

Completed
NCT04369742Phase 2

Treating COVID-19 With Hydroxychloroquine (TEACH)

Terminated
NCT02257424Phase 1

Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma

Completed
NCT04358068Phase 2

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Terminated
NCT04858633Phase 3

Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19

Unknown
NCT04522466Phase 3

Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients

Terminated
NCT04349228Phase 3

Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals

Withdrawn
NCT01897116Phase 1

A Phase I Trial of Vemurafenib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma

Completed
NCT03400254Phase 1

Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER")

Withdrawn
NCT02079077Not Applicable

Inducing Immune Quiescence to Prevent HIV Infection in Women

Completed
NCT02379650Phase 2

Hydroxychloroquine (HCQ) for Recurrent Pregnancy Loss

Withdrawn

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16